Cargando…
An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis
Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene. About 2000 mutations have been described so far. We setup an ex vivo model of human nasal epithelial cells (HNECs) to study CF patients testing the effect of novel m...
Autores principales: | Di Lullo, A.M., Scorza, M., Amato, F., Comegna, M., Raia, V., Maiuri, L., Ilardi, G., Cantone, E., Castaldo, G., Iengo, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SRL
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463510/ https://www.ncbi.nlm.nih.gov/pubmed/27897275 http://dx.doi.org/10.14639/0392-100X-1328 |
Ejemplares similares
-
Septoplasty: is it possible to identify potential “predictors” of surgical success?
por: CANTONE, E., et al.
Publicado: (2018) -
Mathematical model for preoperative identification
of obstructed nasal subsites
por: Gamerra, M., et al.
Publicado: (2017) -
Impact of extended sinus surgery on allograft infection, allograft function and overall survival in cystic fibrosis lung transplant recipients
por: Meier, Manuel, et al.
Publicado: (2023) -
Effects of CFTR-modulator triple therapy on sinunasal symptoms in children and adults with cystic fibrosis
por: Bode, Sebastian F. N., et al.
Publicado: (2023) -
TAS2R38 is a novel modifier gene in patients with cystic fibrosis
por: Castaldo, Alice, et al.
Publicado: (2020)